India, Feb. 10 -- The production of these new grades of Vitamin B3 will significantly enhance the Company's presence within value-added products
Jubilant Ingrevia Limited announced the commissioning of its new cGMP-compliant facility at Bharuch, Gujarat. The new facility will manufacture Nutraceuticals and Dietary-Active ingredients for human consumption. The facility is an extension of the company's USFDA-approved plant that is already supplying to the U.S., Europe, Japan and many other markets. It will be fully equipped to cater to the needs of the biggest marquee customers in the nutrition and cosmetics space.Customers seeking greener supply chains and high bio-content in their inputs will especially stand to benefit. The Niacinamide ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.